Right Ventricular Echocardiography in caRdiac SurgEry
ReVERSE
Response in Right Ventricular Function to Change in Afterload, Preload and Inspired Oxygen in Patients Undergoing Coronary Artery Bypass Graft Surgery
1 other identifier
interventional
30
1 country
1
Brief Summary
Postoperative right ventricular (RV) dysfunction increases mortality and risk of cardiac failure after cardiac surgery substantially. A comprehensive understanding of this condition is paramount in order to achieve success in treatment and early diagnosis. This study has two main aims. Perioperative aim: To investigate correlations between changes in echocardiographic measurements and hemodynamic changes at baseline and following coronary artery bypass graft (CABG) surgery. Postoperative aim: To evaluate changes in haemodynamics and echocardiographic parameters during separate physiological interventions (increase in preload/afterload, oxygen fraction, pacing modes (AAI/DDD/VVI)).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 4, 2017
CompletedFirst Submitted
Initial submission to the registry
September 19, 2017
CompletedFirst Posted
Study publicly available on registry
October 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 5, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2017
CompletedJanuary 9, 2018
January 1, 2018
5 months
September 19, 2017
January 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in right ventricular function during CABG assessed with TAPSE
Assessing the change in RV function during CABG surgery
During a standard CABG operation
Secondary Outcomes (26)
Right ventricular function assessed with TAPSE after each intervention
Immediate postoperative period
Change in cardiac output measured with Swan-Ganz during CABG
During a standard CABG operation
Change in cardiac output measured with Swan-Ganz after each intervention
Immediate postoperative period
Response in right ventricular function parameter S' to each intervention
Immediate postoperative period
Response in right ventricular function parameter S' during CABG
During a standard CABG operation
- +21 more secondary outcomes
Study Arms (1)
All patients
OTHERAll patients will receive the treatment (CABG) and postoperatively three different interventions: 1. Change in preload and afterload 2. Change in inspired oxygen 3. Change in pacemaker modes
Interventions
Afterload: Three levels of positive end-expiratory pressure (PEEP) will be examined post-operatively: 0 cm H20, 5 cm H2O, 10 cm H2O Preload: Trendelenburg position for 5 minutes will be investigated
Following fractions of inspired O2 will be investigated: 0.5 and 1.0 for 10 minutes respectively
Following pacemaker settings will be investigated: Atrioventricular pacing 10 bpm over the patients' intrinsic rhythm, atrial pacing 10 bpm over the patients' intrinsic rhythm, ventricular pacing 10 bpm over the patients' intrinsic rhythm
Eligibility Criteria
You may qualify if:
- Elective coronary artery bypass graft patients
- Normal left ventricular function defined as LVEF over 50 % on TTE preoperatively
You may not qualify if:
- Pre-existing right ventricular malformations
- Severe right ventricular impairment preoperatively
- Pre-existing non-sinus rhythm
- Pre-existing mitral valve stenosis or severe regurgitation
- Pre-existing pulmonary hypertension
- Pre-existing tricuspid valve stenosis or severe regurgitation
- Patients with contraindication to TEE probe placement such as oesophageal stricture or obstruction
- Patients with contraindication to Swan-Ganz catheter placement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rigshospitalet
Copenhagen, Capital Region, 2100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lars Grønlykke, MD
Rigshospitalet, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator, MD
Study Record Dates
First Submitted
September 19, 2017
First Posted
October 4, 2017
Study Start
May 4, 2017
Primary Completion
October 5, 2017
Study Completion
October 5, 2017
Last Updated
January 9, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share